deltatrials
Active Not Recruiting PHASE3 INTERVENTIONAL 2-arm NCT01916317

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Sponsor: All India Institute of Medical Sciences

Conditions Operable Breast Cancer
Interventions 0.5% lignocaine 60mM
Updated 14 times since 2017 Last updated: Apr 8, 2025 Started: Dec 12, 2011 Primary completion: Oct 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Operable Breast Cancer, this trial is ongoing. The trial is conducted by All India Institute of Medical Sciences and has accumulated 14 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Apr 2020 · 15 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Apr 2022 · 11 months · monthly snapshot~Apr 2022 – ~Dec 2023 · 20 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~May 2025 · 3 months · monthly snapshot~May 2025 – ~Jul 2025 · 2 months · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE3

  2. Jul 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE3

  3. May 2025 — Jul 2025 [monthly]

    Active Not Recruiting PHASE3

  4. Feb 2025 — May 2025 [monthly]

    Active Not Recruiting PHASE3

  5. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting PHASE3

▶ Show 9 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  2. Dec 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

  3. Apr 2022 — Dec 2023 [monthly]

    Active Not Recruiting PHASE3

  4. May 2021 — Apr 2022 [monthly]

    Active Not Recruiting PHASE3

  5. Jan 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE3

  6. Apr 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  7. Jan 2019 — Apr 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  8. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE3

  9. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • All India Institute of Medical Sciences
  • Basavatarakam Indo American Cancer Hospital & Research Institute
  • Dr. B Barooha Cancer Institute (BBCI)
  • Gujarat Cancer & Research Institute
  • Kolhapur Cancer Centre (KCC)
  • Malabar Cancer Centre (MCC)
  • Max Super Speciality Hospital
  • North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS)
  • Shri Siddhivinayak Ganpati Cancer Hospital
  • Sterling Multi Speciality Hospital (SMSH)
  • Tata Memorial Hospital
Data source: Tata Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ahmedabad, India , Delhi, India , Guwahati, India , Hyderabad, India , Kannur, India , Kolhāpur, India , Mumbai, India , New Delhi, India , Pune, India , Sangli, India and 1 more location